“Spicing Up” of the Immune System by Curcumin
暂无分享,去创建一个
[1] J. Gertsch,et al. Curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells. , 2003, Bioorganic & medicinal chemistry.
[2] K. M. Nadkarni. The Indian Materia Medica , 1927, The Indian Medical Gazette.
[3] A. Lumsden,et al. Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. , 2005, Journal of the American College of Surgeons.
[4] M. Sugano,et al. Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. , 1996, Bioscience, biotechnology, and biochemistry.
[5] B. Timmermann,et al. The effect of turmeric extracts on inflammatory mediator production. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[6] K. Srinivasan,et al. Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat , 1995, Molecular and Cellular Biochemistry.
[7] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[8] M. Sugano,et al. Effects of dietary fats and curcumin on IgE-mediated degranulation of intestinal mast cells in brown Norway rats. , 1996, Bioscience, biotechnology, and biochemistry.
[9] V. Kapoor,et al. Anti-inflammatory studies on Curcuma longa (turmeric). , 1971, The Indian journal of medical research.
[10] D. Flynn,et al. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. , 1986, Prostaglandins, leukotrienes, and medicine.
[11] S. Seth,et al. Medicinal plants in India. , 2004, The Indian journal of medical research.
[12] J. Remacle,et al. Is the Effect of Interleukin-1 on Glutathione Oxidation in Cultured Human Fibroblasts Involved in Nuclear Factor-κB Activation? , 2001 .
[13] R. Puvanakrishnan,et al. Protective role of curcumin against isoproterenol induced myocardial infarction in rats , 1996, Molecular and Cellular Biochemistry.
[14] L. Howells,et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.
[15] M. Bertagnolli,et al. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. , 2000, The Journal of surgical research.
[16] Ashutosh Kumar Singh,et al. Enhancement of wound healing by curcumin in animals , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[17] H. Cheng,et al. [Protective effect of curcumin on myocardial ischemia reperfusion injury in rats]. , 2005, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.
[18] V. Singh,et al. Immunomodulatory Effects of Curcumin , 2005, Immunopharmacology and immunotoxicology.
[19] M. Azuine,et al. Chemoprevention of mammary tumor virus-induced and chemical carcinogen-induced rodent mammary tumors by natural plant products , 2004, Breast Cancer Research and Treatment.
[20] M. Chan,et al. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. , 1998, Biochemical pharmacology.
[21] B. Aggarwal,et al. Curcumin‐induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B‐Raf/mitogen‐activated/extracellular signal‐regulated protein kinase pathway and the Akt pathway , 2005, Cancer.
[22] G. Bernardi,et al. Curcumin Inhibits Activation of Vγ9Vδ2 T Cells by Phosphoantigens and Induces Apoptosis Involving Apoptosis-Inducing Factor and Large Scale DNA Fragmentation1 , 2001, The Journal of Immunology.
[23] B. Joe,et al. Dietary n-3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages , 2004, Molecular and Cellular Biochemistry.
[24] L. Xinjian,et al. Effect of curcumin on immune function of mice , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].
[25] Yung-Hyun Choi,et al. Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. , 2006, Oncology reports.
[26] V. Kalra,et al. Curcumin, the active constituent of turmeric, inhibits amyloid peptide‐induced cytochemokine gene expression and CCR5‐mediated chemotaxis of THP‐1 monocytes by modulating early growth response‐1 transcription factor , 2004, Journal of neurochemistry.
[27] K. Singletary,et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. , 1996, Cancer letters.
[28] J. Holy. Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. , 2002, Mutation research.
[29] A. Gomez-Muñoz,et al. Curcumin attenuates DNB-induced murine colitis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[30] B. Evers,et al. Curcumin Inhibits Neurotensin-Mediated Interleukin-8 Production and Migration of HCT116 Human Colon Cancer Cells , 2006, Clinical Cancer Research.
[31] B. Aggarwal,et al. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. , 2005, Biochemical pharmacology.
[32] B. Ghosh,et al. Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. , 1999, International journal of immunopharmacology.
[33] Z. Yuan,et al. Curcumin ameliorates left ventricular function in rabbits with pressure overload: inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinase-2 expression. , 2004, Biological & pharmaceutical bulletin.
[34] H. Ohshima,et al. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. , 1995, Biochemical and biophysical research communications.
[35] Udaykumar Ranga,et al. Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription* , 2004, Journal of Biological Chemistry.
[36] L. Chaudhary,et al. Regulation of Interleukin-8 Gene Expression by Interleukin-1β, Osteotropic Hormones, and Protein Kinase Inhibitors in Normal Human Bone Marrow Stromal Cells* , 1996, The Journal of Biological Chemistry.
[37] C. Crumpacker,et al. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[38] L. O’Neill,et al. Inhibition of nuclear factor kappaB by direct modification in whole cells--mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. , 1998, Biochemical pharmacology.
[39] Changguo Chen,et al. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. , 2003, The Journal of surgical research.
[40] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[41] H. Uzun,et al. Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis. , 2006, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.
[42] N. Vanittanakom,et al. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). , 1995, Journal of ethnopharmacology.
[43] H. S. Warren,et al. Toll-like receptors. , 2005, Critical care medicine.
[44] Tirunelveli S. Ramalingam,et al. Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma , 2004, Clinical Cancer Research.
[45] W. Glasgow,et al. Curcumin Suppresses Interleukin 1β-Mediated Microsomal Prostaglandin E Synthase 1 by Altering Early Growth Response Gene 1 and Other Signaling Pathways , 2005, Journal of Pharmacology and Experimental Therapeutics.
[46] W. R. Bishop,et al. Farnesyl Transferase Inhibitors: Mechanism of Action, Translational Studies and Clinical Evaluation , 2003, Cancer biology & therapy.
[47] B. Lokesh,et al. Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. , 1996, Toxicology.
[48] Hao Jiang,et al. Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. , 2003, Molecular cancer therapeutics.
[49] P. Méndez-Samperio,et al. Roles of intracellular calcium and NF-kappaB in the Bacillus Calmette-Guérin-induced secretion of interleukin-8 from human monocytes. , 2001, Cellular immunology.
[50] K. Miyake,et al. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. , 2006, Biochemical pharmacology.
[51] B. Aggarwal,et al. Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.
[52] G. Kuttan,et al. Immunomodulatory activity of curcumin. , 1999, Immunological investigations.
[53] S. Dulchavsky,et al. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. , 2004, Molecular cancer therapeutics.
[54] Z. Gil,et al. Curcumin: A new radio-sensitizer of squamous cell carcinoma cells , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[55] A. Khar,et al. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells , 2000, FEBS letters.
[56] Chang-sheng Deng,et al. Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. , 2006, World journal of gastroenterology.
[57] S. Jee,et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.
[58] R. Srimal,et al. Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent * , 1973, The Journal of pharmacy and pharmacology.
[59] M. K. Heng,et al. Drug‐induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters , 2000, The British journal of dermatology.
[60] R. Srivastava. Inhibition of neutrophil response by curcumin , 1989, Agents and Actions.
[61] E. Bahraoui,et al. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. , 1998, Research in virology.
[62] C. Ho,et al. Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. , 1995, Cancer letters.
[63] M. Rezvani,et al. Modification of radiation‐induced acute oral mucositis in the rat , 2004, International journal of radiation biology.
[64] Y. Surh,et al. Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. , 2005, Antioxidants & redox signaling.
[65] A. Takeshita,et al. CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts , 1996, Infection and immunity.
[66] M. Guenounou,et al. Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. , 2002, Cytokine.
[67] M. Ladanyi,et al. EWS-CREB1: A Recurrent Variant Fusion in Clear Cell Sarcoma—Association with Gastrointestinal Location and Absence of Melanocytic Differentiation , 2006, Clinical Cancer Research.
[68] P. But,et al. Pharmacology and applications of chinese materia medica , 1986 .
[69] Jing-Gung Chung,et al. Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. , 2006, Anticancer research.
[70] Yuetsu Tanaka,et al. Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. , 2006, Leukemia research.
[71] B. Joe,et al. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. , 1994, Biochimica et biophysica acta.
[72] K. Srinivasan,et al. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats , 2004, Molecular and Cellular Biochemistry.
[73] P. Negi,et al. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. , 1999, Journal of agricultural and food chemistry.
[74] Yuetsu Tanaka,et al. Retracted: Curcumin (diferuloylmethane) inhibits constitutive active NF‐κB, leading to suppression of cell growth of human T‐cell leukemia virus type I‐infected T‐cell lines and primary adult T‐cell leukemia cells , 2006 .
[75] R. Smart,et al. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. , 1988, Cancer research.
[76] V. Lampe,et al. Studien über Curcumin , 1913 .
[77] S. Han,et al. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. , 1999, Clinical immunology.
[78] Soon-Cheol Ahn,et al. Curcumin Inhibits Immunostimulatory Function of Dendritic Cells: MAPKs and Translocation of NF-κB as Potential Targets1 , 2005, The Journal of Immunology.
[79] D. Shoskes. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. , 1998, Transplantation.
[80] M. Chan. Inhibition of tumor necrosis factor by curcumin, a phytochemical. , 1995, Biochemical pharmacology.
[81] C. Boland,et al. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. , 2001, Cancer letters.
[82] G. Kuttan,et al. Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.
[83] J. Funk,et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. , 2006, Journal of natural products.
[84] S. Hoffman,et al. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. , 2004, American journal of respiratory cell and molecular biology.
[85] D. Shoskes,et al. Quercetin and curcumin up-regulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury. , 2001, Transplantation proceedings.
[86] Y. Song,et al. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. , 2003, Carcinogenesis.
[87] P. Ortiz de Montellano,et al. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. , 1993, Bioorganic & medicinal chemistry.
[88] D. Sohn,et al. A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria. , 2001, Planta medica.
[89] Joon-Oh Park,et al. Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. , 2005, Biochemical and biophysical research communications.
[90] G. Cole,et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.
[91] B. Aggarwal,et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 , 2003 .
[92] L. Sarma,et al. Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage. , 1993, Mutation research.
[93] D. Sohn,et al. A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-α release from Curcuma zedoaria , 2001 .
[94] S. Gautam,et al. Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. , 1997, Hematopathology and molecular hematology.
[95] Y. Murakami,et al. Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, alpha-diisoeugenol. , 2005, Anticancer research.
[96] M. Festing,et al. Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[97] N. Nalini,et al. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats , 2002, Plant foods for human nutrition.
[98] M. Nair,et al. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[99] L. Elliott,et al. Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. , 1998, The Journal of surgical research.
[100] Y. Surh,et al. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. , 2002, Journal of biochemistry and molecular biology.
[101] H. Kishida,et al. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. , 2005, Biological & pharmaceutical bulletin.
[102] A. Garg,et al. Chemosensitization and radiosensitization of tumors by plant polyphenols. , 2005, Antioxidants & redox signaling.
[103] Fusheng Yang,et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.
[104] M. Dikshit,et al. Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. , 1995, The Indian journal of medical research.
[105] Bao Q. Pham,et al. Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B* , 2000, The Journal of Biological Chemistry.
[106] Jeen-Woo Park,et al. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. , 2006, Carcinogenesis.
[107] T. Horie,et al. Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. , 1997, Biochemical pharmacology.
[108] V. Mohan,et al. Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications , 2003, Journal of Biosciences.
[109] Mansoor M Ahmed,et al. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3 , 2004, Oncogene.
[110] J. Exon,et al. Dietary curcumin enhances antibody response in rats. , 1997, Immunopharmacology and immunotoxicology.
[111] V. Steele,et al. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. , 1996, Carcinogenesis.
[112] Yan-TingJian,et al. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid , 2005 .
[113] J. Hoidal,et al. Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. , 1998, American journal of physiology. Heart and circulatory physiology.
[114] S. Hwang,et al. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. , 1999, European journal of pharmacology.
[115] S. Katz,et al. Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study , 2005, Digestive Diseases and Sciences.
[116] Ashutosh Kumar Singh,et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[117] A. Olson,et al. Active site binding modes of curcumin in HIV-1 protease and integrase. , 2005, Bioorganic & medicinal chemistry letters.
[118] N. Ghatak,et al. Anti-inflammatory and irritant activities of curcumin analogues in rats , 1982, Agents and Actions.
[119] Y. Yuzawa,et al. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. , 2004, Journal of the American Society of Nephrology : JASN.
[120] H. Ammon,et al. Pharmacology of Curcuma longa , 1991, Planta medica.
[121] J. Bright,et al. Curcumin Inhibits Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through Janus Kinase-STAT Pathway in T Lymphocytes1 , 2002, The Journal of Immunology.
[122] C. Rao,et al. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. , 1995, Cancer research.
[123] T. Horie,et al. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. , 1999, Pharmacological research.
[124] V. Menon,et al. Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[125] Fei Wang,et al. The Sensitive Fluorimetric Method for the Determination of Curcumin Using the Enhancement of Mixed Micelle , 2006, Journal of Fluorescence.
[126] S. K. Abraham,et al. Protective effects of chlorogenic acid, curcumin and β-carotene against γ-radiation-induced in vivo chromosomal damage , 1993 .
[127] B. Aggarwal,et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. , 2003, Carcinogenesis.
[128] L. Stanberry,et al. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. , 1999, Antiviral research.
[129] P. Seth,et al. Differential Regulation of Cytokines and Transcription Factors in Liver by Curcumin Following Hemorrhage/Resuscitation , 2003, Shock.
[130] Yung-Hyun Choi,et al. Curcumin decreases binding of shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-α and IL-1β : Suppression of p38, JNK and NF-κB p65 as potential targets , 2006 .
[131] A. Conney,et al. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. , 1991, Cancer research.
[132] Jong-Wook Park,et al. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). , 2005, Carcinogenesis.
[133] T. Ogawa,et al. Gene Expressions of Toll-Like Receptor 2, But Not Toll-Like Receptor 4, Is Induced by LPS and Inflammatory Cytokines in Mouse Macrophages1 , 2000, The Journal of Immunology.
[134] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[135] Y. Ko,et al. Effects of nuclear factor‐κB inhibitors and its implication on natural killer T‐cell lymphoma cells , 2005, British journal of haematology.
[136] K. Piwocka,et al. Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. , 1997, Biochemical pharmacology.
[137] K. Piwocka,et al. Effect of Curcumin on the Apoptosis of Rodent and Human Nonproliferating and Proliferating Lymphoid Cells , 2000, Nutrition and cancer.
[138] Daniel Normolle,et al. Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.
[139] M. Kitamura,et al. Unexpected Transcriptional Induction of Monocyte Chemoattractant Protein 1 by Proteasome Inhibition: Involvement of the c-Jun N-Terminal Kinase-Activator Protein 1 Pathway1 , 2001, The Journal of Immunology.
[140] Joon-Oh Park,et al. Curcumin inhibits interferon-α induced NF-κB and COX-2 in human A549 non-small cell lung cancer cells , 2005 .
[141] A. Conney,et al. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. , 1992, Carcinogenesis.
[142] Y. Lou,et al. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. , 1994, Cancer research.
[143] S. Dulchavsky,et al. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. , 2004, Biochemical pharmacology.
[144] D. Brenner,et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.
[145] Mao-tsun Lin,et al. Blocking NF-kappaB activation may be an effective strategy in the fever therapy. , 2003, The Japanese journal of physiology.
[146] J. Weinstein,et al. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. , 1995, Biochemical pharmacology.
[147] W. Hunter,et al. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis , 2006, Inflammation Research.
[148] Yuetsu Tanaka,et al. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. , 2006, International journal of cancer.
[149] R. Steinman,et al. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins , 1990, The Journal of experimental medicine.
[150] A. Gescher,et al. Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials. , 2006, European journal of cancer.
[151] Babu P. Patlolla,et al. Effect of Turmeric, Turmerin and Curcumin on Ca2+, Na/K+ Atpases in Concanavalin A-Stimulated Human Blood Mononuclear Cells , 2003 .
[152] S. Hwang,et al. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin‐12 production in macrophages , 1999, British journal of pharmacology.
[153] B. Bosman. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[154] B. Jang,et al. Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets , 2005, Experimental & Molecular Medicine.
[155] S. Sang,et al. Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase , 2004 .
[156] M. Ogawa,et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface , 2002, Cancer.
[157] Jide Wang,et al. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. , 2005, World journal of gastroenterology.
[158] B. Aggarwal,et al. Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. , 2006, Toxicology.
[159] Ricky A. Sharma,et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[160] G. Wu,et al. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. , 1998, The American surgeon.
[161] S. Pal,et al. Curcumin induces apoptosis in human breast cancer cells through p53‐dependent Bax induction , 2002, FEBS letters.
[162] S. Gautam,et al. Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. , 1997, Experimental hematology.
[163] Jen-kun Lin,et al. Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. , 1996, Nutrition and cancer.
[164] F. Sallusto,et al. Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.
[165] Ping Wang,et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-γ* , 2006 .
[166] J. Sayre,et al. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. , 2006, Journal of Alzheimer's disease : JAD.
[167] B. Ghosh,et al. Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. , 2003, Biological & pharmaceutical bulletin.
[168] S. Dulchavsky,et al. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-KB through suppression of IKBA phosphorylation , 2004 .
[169] Jen-kun Lin,et al. Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.
[170] J. Miłobȩdzka,et al. Zur Kenntnis des Curcumins , 1897 .
[171] K. Mohri,et al. Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. , 2005, Biological & pharmaceutical bulletin.
[172] P. Murugan,et al. Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. , 2006, Life sciences.